Journal of Pharmaceutical Research and Innovation invites integrative reviews of current advances in translational research pertinent to emerging areas of nursing science. Subjects of interest include but are not limited to themes in medical and pharmaceutical research, healthcare policies, clinical breakthroughs, clinical management, drug information and clinical news, drug research and discoveries, drug delivery- quality, safety & efficacy and clinical practice. Other areas include clinical chemistry, pharmacogenetics, precision medicine, targeted drug delivery, challenges in pharmaceutical research, drug discovery & screening, phenotypic drug delivery, pharmaceutical analysis & quality assurance, bio-drugs & therapeutics, drug delivery affairs, development of clinical interventions, neuroscience and imaging; computational biology, information technology at the point of care, physiology in situ and mobile health devices, system interoperability and emerging technology-supported point-of-care settings and inhaled drug delivery. Biology reviews should provide latest information about advances in these areas with the goal of infusing new biological knowledge into nursing research. Reviews should summarize and critically evaluate the current state of knowledge. Implications for nursing research in relevant areas should be addressed, especially with respect to the priority research addressing symptoms and symptom management of acute and chronic illnesses, prevention and treatment of disease and disability, infectious disease and global health, interventions for compassionate end-of-life and palliative care and integration of biological and behavioural outlooks on health across priority areas.